Abstract
Endothelial cell therapy has been implicated to enhance tissue regeneration and vascularization in ischemic kidney. However, no published study has yet examined direct effects of endothelial cell treatment in kidney recovery. This study investigated the therapeutic efficacy of endothelial cells in a mouse model with acute kidney injury (AKI). Thus, human embryonic stem cells-derived endothelial cells (hESC-ECs) labeled with a reporter system encoding a double fusion reporter gene for firefly luciferase (Fluc) and green fluorescent protein (GFP) were characterized by Fluc imaging and immunofluoresence staining. Cultured hESC-ECs (1×106) were injected into ischemic kidney shortly after AKI. Survival of the transplanted hESC-ECs was monitored in vivo from day 1 to 14 after endothelial cell transplantation and potential impact of hESC-EC treatment on renal regeneration was assessed by histological analyses. We report that a substantial level of bioluminescence activity was detected 24 h after hESC-EC injection followed by a gradual decline from 1 to 14 d. Human ESC-ECs markedly accelerated kidney cell proliferation in response to ischaemia-induced damage, indicated by an elevated number of BrdU+ cells. Co-expression of Sca-1, a kidney stem cell proliferation marker, and BrdU further suggested that the observed stimulation in renal cell regeneration was, at least in part, due to increased proliferation of renal resident stem cells especially within the medullary cords and arteriole. Differentiation of hESC-ECs to smooth muscle cells was also observed at an early stage of kidney recovery. In summary, our results suggest that endothelial cell therapy facilitates kidney recovery by promoting vascularization, trans-differentiation and endogenous renal stem cell proliferation in AKI.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Patschan D, Patschan S, Muller G A. Endothelial progenitor cells in acute ischemic kidney injury: Strategies for increasing the cells’ renoprotective competence. Int J Nephrol, 2011, 828369
Munshi R, Hsu C, Himmelfarb J. Advances in understanding ischemic acute kidney injury. BMC Med, 2011, 9: 11
Strauer B E, Kornowski R. Stem cell therapy in perspective. Circulation, 2003, 107: 929–934
Brodsky S V, Gao S, Li H, et al. Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells. Am J Physiol Heart Circ Physiol, 2002, 283: H2130–2139
Yamamoto T, Tada T, Brodsky S V, et al. Intravital videomicroscopy of peritubular capillaries in renal ischemia. Am J Physiol Renal Physiol, 2002, 282: F1150–1155
Kumar A H, Caplice N M. Clinical potential of adult vascular progenitor cells. Arterioscler Thromb Vasc Biol, 2010, 30: 1080–1087
Cheung C, Sinha S. Human embryonic stem cell-derived vascular smooth muscle cells in therapeutic neovascularisation. J Mol Cell Cardiol, 2011, 51: 651–664
Morigi M, Rota C, Montemurro T, et al. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells, 2010, 28: 513–522
Liu Y, Ye Z, Wang Y, et al. Induction-dependent neural marker expression and electrophysiological characteristics of bone marrow mesenchymal stem cells that naturally express high levels of nestin. Chin Sci Bull, 2011, 56: 640–646
Li D, Wang W, Guo R, et al. Restoration of rat calvarial defects by poly(lactide-do-glycolide)/hydroxyapatite scaffolds loaded with bone mesenchymal stem cells and DNA complexes. Chin Sci Bull, 2012, 57: 435–444
Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med, 2005, 353: 999–1007
Levenberg S, Zoldan J, Basevitch Y, et al. Endothelial potential of human embryonic stem cells. Blood, 2007, 110: 806–814
Li Z, Han Z, Wu J C. Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases. J Cell Biochem, 2009, 106: 194–199
Li Z, Wilson K D, Smith B, et al. Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction. PLoS One, 2009, 4: e844
Huang N F, Niiyama H, Peter C, et al. Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion. Arterioscler Thromb Vasc Biol, 2010, 30: 984–991
Oyamada N, Itoh H, Sone M, et al. Transplantation of vascular cells derived from human embryonic stem cells contributes to vascular regeneration after stroke in mice. J Transl Med, 2008, 6: 54
Li Z, Wu J C, Sheikh A Y, et al. Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation, 2007, 116: I46–54
Cho S W, Moon S H, Lee S H, et al. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation, 2007, 116: 2409–2419
Uchimura H, Marumo T, Takase O, et al. Intrarenal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cell activation in experimental glomerulonephritis. J Am Soc Nephrol, 2005, 16: 997–1004
Gnecchi M, Zhang Z, Ni A, et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res, 2008, 103: 1204–1219
Sangidorj O, Yang S H, Jang H R, et al. Bone marrow-derived endothelial progenitor cells confer renal protection in a murine chronic renal failure model. Am J Physiol Renal Physiol, 2010, 299: F325–335
Li Z, Suzuki Y, Huang M, et al. Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells, 2008, 26: 864–873
Li Z, Lee A, Huang M, et al. Imaging survival and function of transplanted cardiac resident stem cells. J Am Coll Cardiol, 2009, 53: 1229–1240
Yu J, Huang N F, Wilson K D, et al. nAChRs mediate human embryonic stem cell-derived endothelial cells: Proliferation, apoptosis, and angiogenesis. PLoS One, 2009, 4: e7040
Kwon O, Miller S, Li N, et al. Bone marrow-derived endothelial progenitor cells and endothelial cells may contribute to endothelial repair in the kidney immediately after ischemia-reperfusion. J Histochem Cytochem, 2010, 58: 687–694
Brodsky S V, Yamamoto T, Tada T, et al. Endothelial dysfunction in ischemic acute renal failure: Rescue by transplanted endothelial cells. Am J Physiol Renal Physiol, 2002, 282: F1140–1149
Kofidis T, Lebl D R, Martinez E C, et al. Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation, 2005, 112: I173–177
Frid M G, Kale V A, Stenmark K R. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: In vitro analysis. Circ Res, 2002, 90: 1189–1196
Liebner S, Cattelino A, Gallini R, et al. Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J Cell Biol, 2004, 166: 359–367
Sallustio F, De Benedictis L, Castellano G, et al. TLR2 plays a role in the activation of human resident renal stem/progenitor cells. FASEB J, 2010, 24: 514–525
Parikh C R, Lu J C, Coca S G, et al. Tubular proteinuria in acute kidney injury: A critical evaluation of current status and future promise. Ann Clin Biochem, 2010, 47: 301–312
Yeagy B A, Cherqui S. Kidney repair and stem cells: A complex and controversial process. Pediatr Nephrol, 2011, 26: 1427–1434
Dekel B, Zangi L, Shezen E, et al. Isolation and characterization of nontubular sca-1+lin-multipotent stem/progenitor cells from adult mouse kidney. J Am Soc Nephrol, 2006, 17: 3300–3314
Burchfield J S, Dimmeler S. Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis. Fibrogenesis Tissue Repair, 2008, 1: 4
Author information
Authors and Affiliations
Corresponding authors
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Jia, X., Lü, H., Li, C. et al. Human embryonic stem cells-derived endothelial cell therapy facilitates kidney regeneration by stimulating renal resident stem cell proliferation in acute kidney injury. Chin. Sci. Bull. 58, 2820–2827 (2013). https://doi.org/10.1007/s11434-013-5890-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11434-013-5890-3